Biomea Fusion, Inc. Short-term Lease, Cost
Biomea Fusion, Inc. (BMEA) reported Short-term Lease, Cost of $28.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ShortTermLeaseCost · last filed 2026-03-24
- Biomea Fusion, Inc. short-term lease, cost for the quarter ending 2022-12-31 was $636.00K.
- Biomea Fusion, Inc. short-term lease, cost for the quarter ending 2022-09-30 was $773.00K.
- Biomea Fusion, Inc. short-term lease, cost for the quarter ending 2022-06-30 was $759.00K.
- Biomea Fusion, Inc. short-term lease, cost for the quarter ending 2022-03-31 was $753.00K.
- Biomea Fusion, Inc. short-term lease, cost for fiscal 2025 was $28.00K.
- Biomea Fusion, Inc. short-term lease, cost for fiscal 2022 was $2.92M, a 335.32% increase from fiscal 2021.
- Biomea Fusion, Inc. short-term lease, cost for fiscal 2021 was $671.00K.
| Period end | Short-term Lease, Cost 3 month | Short-term Lease, Cost 6 month | Short-term Lease, Cost 9 month | Short-term Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $28.00K 10-K · filed 2026-03-24 | |||
| 2022-12-31 | $636.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.41M derived: sum of 2 quarters · filed 2025-03-31 | $2.17M derived: sum of 3 quarters · filed 2025-03-31 | $2.92M 10-K · filed 2025-03-31 |
| 2022-09-30 | $773.00K 10-Q · filed 2023-10-30 | $1.53M derived: sum of 2 quarters · filed 2023-10-30 | $2.29M 10-Q · filed 2023-10-30 | |
| 2022-06-30 | $759.00K 10-Q · filed 2023-07-31 | $1.51M 10-Q · filed 2023-07-31 | ||
| 2022-03-31 | $753.00K 10-Q · filed 2023-05-02 | |||
| 2021-12-31 | $671.00K 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |